3RD ESO LUNG CANCER OBSERVATORY: INNOVATION AND CARE IN THE NEXT 12 MONTHS
Therapeutic management of unresectable stage III NSCLC: An update
F. Mornex
Therapeutic management of unresectable stage III NSCLC: An update
F. Mornex